Major medtech conference moves to Victoria


By AusBiotech
Wednesday, 30 January, 2013


Major medtech conference moves to Victoria

AusMedtech 2013, Australia’s premier medical technology conference, will be held in Melbourne for the first time on 15-16 May, with the support of the state government of Victoria.

AusMedtech, now in its sixth year, will be held in Melbourne for the first time, with the support of the state government of Victoria. AusMedtech 2013 is Australia’s premier medical technology conference and registrations are now open for the 15-16 May event.

AusMedtech 2013 will provide executives with business partnering opportunities, a topical and comprehensive speaking program that addresses key issues, a special briefing by the Victorian Government, a world-class professional development course and trade exhibition.

The global medical technology market is valued at US$300 billion a year and is one of the fastest-growing markets in the world, growing at a rate of 10% per year. Australia is the fourth-largest market by revenue for medical devices and the third-largest for diagnostics in the Asia-Pacific, joining Japan, China, South Korea and India in the top five.

The industry is advancing rapidly into new fields of science and engineering, with nanotechnology and other research developments expected to facilitate new innovations in the biomedical sphere and an increasing convergence of physical and biological technology platforms.

AusMedtech 2013 brings together the medical devices and diagnostics sector to discuss the major issues in global medtech success with a focus on emerging markets. This year’s conference will be held at The Sebel in Albert Park, 15-16 May.

The AusMedtech conference is held biannually by AusMedtech, part of AusBiotech, Australia’s biotechnology industry organisation. AusMedtech is the national industry group representing the medical devices and diagnostics industry sector.

For further information, registrations, program and sponsorship opportunities, see the AusMedtech 2013 site.

Related Articles

AI-designed DNA switches flip genes on and off

The work creates the opportunity to turn the expression of a gene up or down in just one tissue...

Drug delays tumour growth in models of children's liver cancer

A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma,...

Ancient DNA rewrites the stories of those preserved at Pompeii

Researchers have used ancient DNA to challenge long-held assumptions about the inhabitants of...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd